hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients

Department of Medical Oncology, VU University Medical Center , Amsterdam, the Netherlands.

Research output: Contribution to journal › Article › Academic › peer-review

13 Downloads (Pure)

Access to Document

@article{1570203a78fa4f87a1dc1160b77223d4,

title = "hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients",

author = "Meijer, \{Laura L\} and Puik, \{Jisce R\} and Peters, \{Godefridus J\} and Geert Kazemier and Elisa Giovannetti",

year = "2016",

month = dec,

doi = "10.1634/theoncologist.2016-0262",

language = "English",

volume = "21",

pages = "e4",

journal = "The Oncologist",

issn = "1083-7159",

publisher = "AlphaMed Press",

number = "12",

}

TY - JOUR

T1 - hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients

AU - Meijer, Laura L

AU - Puik, Jisce R

AU - Peters, Godefridus J

AU - Kazemier, Geert

AU - Giovannetti, Elisa

PY - 2016/12

Y1 - 2016/12

U2 - 10.1634/theoncologist.2016-0262

DO - 10.1634/theoncologist.2016-0262

M3 - Article

SN - 1083-7159

VL - 21

SP - e4

JO - The Oncologist

JF - The Oncologist

IS - 12

ER -